TXMD
insider transactionsTherapeuticsMD, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
+8.4K
8.4K buy · 0 sell
Net value · 365d
$14.0K
$14.0K in · $0 out
Sentiment · 365d
Net buying
100% buying · 0% selling
Open-market trades · 365d
1
8.4K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Buy·P
Director
$14.0K
8.4K sh · $1.67
Own +57%
-
Grant·A
Director
$0
8.5K sh
Own New
-
Grant·A
Director
$0
8.5K sh
Own New
-
Grant·A
Walker Marlan D KEY
Chief Executive Officer
$0
67.5K sh
Own New
-
Grant·A
Director
$0
8.5K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Dec 23, 2025 | Thompson Tommy G | Buy P | 8.4K | $14.0K |
| Nov 3, 2025 | Thompson Tommy G | Grant A | 8.5K | $0 |
| Nov 3, 2025 | Collins Cooper C. | Grant A | 8.5K | $0 |
| Nov 3, 2025 | Walker Marlan D KEY | Grant A | 67.5K | $0 |
| Nov 3, 2025 | Naughton Gail K | Grant A | 8.5K | $0 |
About TXMD insider trading
This page tracks insider transactions for TherapeuticsMD, Inc. (TXMD) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.